Known targets — ChEMBL curated mechanism
CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1
The experimentally established mechanism targets of Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 2/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lactic Acid SCHEMBL3446643 | 0.94 | TP53 (0.65) | TP53TSHRSLC7A5CA2CA1 | |
| Lactic Acid SCHEMBL28131108 | 0.94 | TP53 (0.65) | TP53TSHRSLC7A5CA2CA1 | |
| Lactic Acid SCHEMBL10590230 | 0.94 | TP53 (0.65) | TP53TSHRSLC7A5CA2CA1 | |
| Lactic Acid SCHEMBL10590229 | 0.94 | TP53 (0.65) | TP53TSHRSLC7A5CA2CA1 | |
| Lactic Acid SCHEMBL2829311 | 0.94 | TP53 (0.65) | TP53TSHRSLC7A5CA2 | |
| Lactic Acid SCHEMBL18259576 | 0.94 | TP53 (0.65) | TP53TSHRSLC7A5CA2CA1 | |
| Lactic Acid SCHEMBL14976631 | 0.89 | TP53 (0.58) | TP53TSHRSLC7A5 | |
| Lactic Acid SCHEMBL11054103 | 0.89 | TP53 (0.58) | TP53TSHRSLC7A5 | |
| Sulfuric Acid SCHEMBL29053618 | 0.85 | TP53 (0.42) | TP53TSHRSLC7A5CA2CA1 | |
| Lactic Acid SCHEMBL28689966 | 0.83 | TP53 (0.58) | TP53TSHRSLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105018538-B | A method of magnesium lactate is produced based on crystallisation Integrated process | 北京化工大学 | 2018-10-23 | — | — | CN | disclosed |
| US-4152431-A | ANTIINFLAMMATORY AGENTS | WILLIAM H. RORER, INC. (US) | 1979-05-01 | — | — | US | disclosed |